Shareholders meeting

SUVEN~; Life Sciences CSD/BSE&NSE/AGM 2026 Date: August 25, 2026 To To Listing Department, Department of Corporate Services National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Bandra- Kurla Complex, 25th Floor, P. J. Towers, Bandra (E), Mumbai-400 051 Dalal Street, Mumbai - 400 001 Stock Code - SUVEN Stock Code - 530239 Dear Sir/Madam, Sub: Outcome of 37th Annual General Meeting (AGM) held on 25th August, 2026 Pursuant to Regulation 30 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform that the 37th Annual General Meeting (AGM) of the Company was held today i.e. Tuesday, 25th August, 2026 In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure – I 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III This is for your information and record purposes. Thanking you, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary M. No.:A40736 Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com SUVEN. ' Life Sciences Annexure-I SUMMARY OF PROCEEDINGS OF 37th ANNUAL GENERAL MEETING OF SUVEN LIFE SCIENCES LIMITED Meeting Day, Date and Time : Tuesday 25 August, 2026 at 11:30 a.m. The 37th Annual General Meeting (AGM) of the Company was held on Tuesday, 25th August, 2026 at 11:30 a.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Meeting commenced at 11:30 a.m. (IST) and concluded with e-Voting in AGM at 12:23 p.m. (IST). Directors Present: 1. Shri Venkateswarlu Jasti Chairman & MD 2. Smt. Sudharani Jasti Whole-time Director 3. Shri Santanu Mukherjee Independent Director (Chairman – Audit Committee & Chairman – Nomination & Remuneration Committee) 4. Dr. Vajja Sambasiva Rao Independent Director (Chairman – Stakeholders Relationship Committee) 5. Smt. J.A.S. Padmaja Independent Director 6. Prof. Syed Hasnain Non- Executive Director In attendance: 1. Ms. Sangeetha Laxmi Company Secretary 2. Mr. M. Mohan Kumar Chief Financial Officer 3. Mr. Ajay Kumar Kosaraju M/s. KARVY & Co., Statutory Auditors 4. Mr. D.V.M. Gopal M/s. DVM & Associates LLP, Secretarial Auditors 5. Smt. D. Renuka Scrutinizer, Practicing Company Secretary Members Present: The meeting was attended by 152 members through VC / OAVM. Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com SUVEN. ' Life Sciences Ms. Sangeetha Laxmi, Company Secretary, welcomed all Members, Directors and Auditors of the Company to the 37th Annual General Meeting and informed that the Meeting held through VC/ OAVM in compliance with the relevant circulars issued by the Ministry of Corporate Affairs (MCA), Government of India and Securities and Exchange Board of India (SEBI). Shri Venkateswarlu Jasti, the Chairman of the Board took the chair and conducted the proceedings of the Meeting. The requisite quorum being present, the meeting was called to order. The Chairman delivered his speech. The Chairman informed the members that the Auditors' Report and Secretarial Audit report did not contain any adverse remarks. The members were further informed that the notice convening the 37th Annual General Meeting together with audited financial statements for the year ended March 31, 2026, Report of Directors and Auditor's report had been sent to the Members through emails and a letter containing Annual Report web link was sent to the Members of the company whose e-mail IDs are not registered. With the permission of the Members the reports were taken as read. The documents along with the statutory registers were made available for inspection. The Members were further informed that the Company had provided the Members the facility to cast their vote electronically, on all resolutions set forth in the Notice. Remote e- voting was commenced at 9:00 a.m. on Friday, August 21st , 2026 and concluded at 5:00 p.m. on Monday, August 24th, 2026. Members who were present at the AGM and had not exercised their votes electronically through remote e-voting, were provided an opportunity to cast their votes at the end of the meeting through Insta Poll (e-voting). The Chairman then invited the shareholders to ask questions, if any on the accounts, performance of the Company and other matters placed before the AGM. The Shareholders were given an opportunity to speak. Sufficient time to all shareholders given to speak, the Chairman gave responses appropriately to the queries raised by the shareholders. The following items of business were transacted at the meeting: Item Type of Resolutions No. resolution Ordinary Business: 1. To receive, consider and adopt the audited standalone and Ordinary consolidated financial statement of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditor’s thereon Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com SUVEN. ' Life Sciences 2. To appoint a director in place of Prof. Seyed E Hasnain ((DIN: Ordinary 02205199) who retires by rotation, and being eligible, offers himself for re-appointment Special Business: 3. To Approve the Related Party Transaction relating to the Appointment Ordinary of Dr. Madhavi Jasti, MD, to an Office or Place of Profit in Overseas Wholly Owned Subsidiaries of the Company 4. To re-appoint Dr. Vajja Sambasiva Rao (DIN: 09233939) as an Special Independent Director of the Company 5. To approve the variation in the utilization of funds raised through Special Preferential Issue Shri Santanu Mukherjee, Independent Director, chaired the meeting for agenda Item no. 3 of the Notice of the 37th Annual General Meeting and then Shri Santanu Mukherjee handed over the chair back to Shri Venkateswarlu Jasti. Chairman Shri. Venkateswarlu Jasti, informed the shareholders that Smt. D. Renuka, Practicing Company Secretary, Hyderabad was appointed as the Scrutinizer for remote e-voting process and e-voting at the AGM, to report on the voting results for the items as per the notice of the 37th Annual General Meeting in a fair and transparent manner. The Chairman authorized the Company Secretary, to declare the results of voting. The Scrutinizers' Report was received and accordingly all the resolutions as set out in the Notice of the 37th Annual General Meeting were declared as passed by requisite majority. For Suven Life Sciences Limited K.Sangeetha Laxmi Company Secretary M.No.: A40736 Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com Annexure II SUVEN LIFE SCIENCES LIMITED Date of the AGM 25-08-2026 Total number of shareholders on record date 69900 No. of shareholders present in the meeting either in person or through proxy: Promoters and Promoter Group: 0 Public: 0 No. of Shareholders attended the meeting through Video Conferencing Promoters and Promoter Group: 6 Public: 146 Resolution No. 1 Resolution required: (Ordinary/ Special) ORDINARY - Adoption of [Showing first 8,000 characters — download PDF for full document]